Japanese brewing giant Kirin is ending a six-year-old joint venture with Myanmar Economic Holdings Public Company Limited for its links with the country's military after the Myanmar army this week seized power in a coup.
Detained by the Myanmar army are top government officials, including its leader Aung San Suu Kyi.
According to Kirin, it is "deeply concerned by' the recent actions of Myanmar's military and had no choice but to terminate" the partnership.
In 2015, the year of Suu Kyi's landslide election victory, Kirin spent $560 million to buy a majority stake in Myanmar Brewery, the country's top beer company.
Myanmar Economic Holdings Public Company Limited was its local business partner and co-owner.
The company added that it invested in Myanmar in 2015, believing that it could contribute positively to its people and the economy as it entered an important period of democratization.
Kirin has been under pressure to drop its business ties in Myanmar even before this week's coup.
Amnesty International had raised concerns about whether donations made by Myanmar Brewery were used to benefit the country's military.
In 2019, a UN fact-finding mission claimed that Myanmar's military had been using its business ties to support its "brutal operation against ethnic groups."
Kirin has since been investigating its operations in the country, and last November suspended dividend payments to the Myanmar holding company.


Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Italy Fines Apple €98.6 Million Over App Store Dominance
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 



